Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services... Show more
a developer of protein diagnostic platform
Industry MedicalNursingServices
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NBMLX | 14.57 | 0.14 | +0.97% |
| Neuberger Mid Cap Growth Inst | |||
| NMUEX | 12.45 | 0.08 | +0.65% |
| Neuberger Multi-Cap Opportunities E | |||
| ARYYX | 14.35 | 0.06 | +0.42% |
| American Century Global Real Estate Y | |||
| RYBHX | 59.61 | N/A | N/A |
| Rydex S&P MidCap 400 Pure Growth H | |||
| BSTSX | 84.67 | N/A | N/A |
| BlackRock Technology Opportunities Svc | |||
A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with TWST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then TWST could also see price increases.
| Ticker / NAME | Correlation To QTRX | 1D Price Change % | ||
|---|---|---|---|---|
| QTRX | 100% | +2.40% | ||
| TWST - QTRX | 49% Loosely correlated | +0.29% | ||
| ILMN - QTRX | 49% Loosely correlated | +2.57% | ||
| RVTY - QTRX | 45% Loosely correlated | +2.79% | ||
| CRL - QTRX | 44% Loosely correlated | +1.93% | ||
| A - QTRX | 43% Loosely correlated | +2.66% | ||
More | ||||
| Ticker / NAME | Correlation To QTRX | 1D Price Change % |
|---|---|---|
| QTRX | 100% | +2.40% |
| Medical/Nursing Services industry (141 stocks) | 3% Poorly correlated | +0.38% |
| Health Services industry (242 stocks) | 2% Poorly correlated | +0.38% |
The Aroon Indicator for QTRX entered a downward trend on August 19, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 210 similar instances where the Aroon Indicator formed such a pattern. In 193 of the 210 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on August 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QTRX as a result. In 73 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
QTRX moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for QTRX crossed bearishly below the 50-day moving average on August 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QTRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where QTRX's RSI Oscillator exited the oversold zone, 32 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 65 cases where QTRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for QTRX just turned positive on September 04, 2026. Looking at past instances where QTRX's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
Following a +5.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where QTRX advanced for three days, in 212 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
QTRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.508) is normal, around the industry mean (10.685). P/E Ratio (0.000) is within average values for comparable stocks, (67.907). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.653). QTRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.783) is also within normal values, averaging (35.925).
The Tickeron Seasonality Score of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. QTRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QTRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.